Eurofins Viracor Chagas Disease qPCR Test
Eurofins Viracor has launched a qPCR assay for Trypanosoma cruzi, the pathogen that causes Chagas disease. The test incorporates a preanalytical process designed to reduce testing delays and minimize instances of testing not performed, and the company said that it can provide results within 48 hours of sample receipt. The test supports early diagnosis and monitoring of Chagas disease, particularly in high-risk populations such as transplant recipients, where timely detection is critical to preventing disease progression or reactivation, the company said. The test has not been cleared or approved for diagnostic use by the US Food and Drug Administration.